Fears patients let down by imminent medical cannabis deadline
In an industry first, NBR Lister-backed medical cannabis firm Helius has received GMP certification.
Andrew Bevin
Wed, 04 Aug 2021
The government has decided against further delaying the deadline for medical cannabis products to meet New Zealand’s tough standards, a move industry participants say exposes patients to price gouging.
When new laws governing medical cannabis were put in place on April 1, 2020, the tight
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Andrew Bevin
Wed, 04 Aug 2021
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Fears patients let down by imminent medical cannabis deadline
Politics,
88387